Dr Robert Perry, the director of PFC, commented in oral testimony that the leaflets accompanying Factor 8 and 9 concentrates were primarily targeted at the prescribing doctor "and, in a sense, they had a much closer working knowledge of risks of hepatitis non-A, non-B, hepatitis B and, latterly, HIV than the manufacturer of the products. So none of this information would have been a surprise to a treating doctor."